Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-24-003238

Chief Financial Officer gave up 2,512 shares (to pay taxes)

  • Chief Financial Officer acquired 182,849 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Secora Michael · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-02-09 Grant or award : show line 1 in the form +8,659 989,673 D
2024-02-09 Grant or award : show line 2 in the form +174,190 1,163,863 D
2024-02-09 Shares withheld for taxes : show line 3 in the form −2,512 $10.09 $25,346 1,161,351 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2024-02-09 Grant or award : show line 4 in the form Stock Option (Right to Buy) +348,380 $10.09 2034-02-09 348,380 348,380 D
Loading xslF345X05/doc4.xml…